We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAMB
8551
Monarch Ambassador Income Index ETF
MAMB
$190M
$1.34K ﹤0.01%
61
-26
-30% -$571
DSWL icon
8552
Deswell Industries
DSWL
$51.6M
$1.34K ﹤0.01%
+541
New +$1.28K
CRESY
8553
Cresud
CRESY
$795M
$1.34K ﹤0.01%
164
-512
-76% -$4.68K
HELX icon
8554
Franklin Genomic Advancements ETF
HELX
$29.1M
$1.33K ﹤0.01%
+42
New +$1.32K
NKGNW
8555
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$1.32K ﹤0.01%
13,606
-34
-0.2% -$4
RISR icon
8556
FolioBeyond Alternative Income and Interest Rate Hedge ETF
RISR
$296M
$1.32K ﹤0.01%
38
-97
-72% -$3.34K
DDI
8557
DoubleDown Interactive
DDI
$574M
$1.31K ﹤0.01%
100
-2,237
-96% -$25.8K
CTSO icon
8558
Cytosorbents Corp
CTSO
$22.7M
$1.3K ﹤0.01%
1,857
+1,800
+3,158% +$1.56K
DSY
8559
Big Tree Cloud Holdings
DSY
$17.9M
$1.3K ﹤0.01%
+39
New +$1.69K
FLHK
8560
DELISTED
Franklin FTSE Hong Kong ETF
FLHK
$1.3K ﹤0.01%
+80
New +$1.38K
DESK icon
8561
VanEck Office and Commercial REIT ETF
DESK
$14.4M
$1.3K ﹤0.01%
+36
New +$1.27K
SENS icon
8562
Senseonics Holdings Inc
SENS
$263M
$1.29K ﹤0.01%
162
-3,142
-95% -$28K
ZNB
8563
Zeta Network Group
ZNB
$551K
0
TAP.A icon
8564
Molson Coors Class A
TAP.A
$7.73B
$1.29K ﹤0.01%
+23
New +$1.38K
BCSAU
8565
DELISTED
Blockchain Coinvestors Acquisition Corp. I Unit
BCSAU
$1.29K ﹤0.01%
115
+114
+11,400% +$1.27K
ELLO icon
8566
Ellomay Capital Ltd
ELLO
$270M
$1.28K ﹤0.01%
111
+32
+41% +$465
IG icon
8567
Principal Investment Grade Corporate Active ETF
IG
$198M
$1.27K ﹤0.01%
62
-613
-91% -$12.5K
KCGI
8568
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$1.26K ﹤0.01%
114
+63
+124% +$694
EMPD
8569
Empery Digital
EMPD
$79.8M
$1.26K ﹤0.01%
5
+4
+400% +$5.57K
RVPHW
8570
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$1.26K ﹤0.01%
4,661
+2,279
+96% +$935
CAMX icon
8571
Cambiar Aggressive Value ETF
CAMX
$68.1M
$1.25K ﹤0.01%
44
-23
-34% -$666
RATE
8572
DELISTED
Global X Interest Rate Hedge ETF
RATE
$1.25K ﹤0.01%
62
-27
-30% -$561
PBMR icon
8573
PGIM US Large-Cap Buffer 20 ETF March
PBMR
$34.5M
$1.25K ﹤0.01%
+48
New +$1.23K
MDEV icon
8574
First Trust Indxx Medical Devices ETF
MDEV
$3.04M
$1.25K ﹤0.01%
63
-32
-34% -$654
GNFT
8575
DELISTED
Genfit
GNFT
$1.25K ﹤0.01%
+346
New +$1.4K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.